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Toward The ‘Tipping Point’:
Decision Aids And Informed
Patient Choice
Access to high-quality patient decision aids is accelerating, but not at
the point of clinical care.
by Annette M. O’Connor, John E. Wennberg, France Legare, Hilary A.
Llewellyn-Thomas, Benjamin W. Moulton, Karen R. Sepucha, Andrea G.
Sodano, and Jaime S. King
ABSTRACT: Preference-sensitive treatment decisions involve making value trade-offs be-
tween benefits and harms that should depend on informed patient choice. There is strong
evidence that patient decision aids not only improve decision quality but also prevent the
overuse of options that informed patients do not value. This paper discusses progress in
implementing decision aids and the policy prospects for reaching a “tipping point” in the
adoption of “informed patient choice” as a standard of practice. [Health Affairs 26, no. 3
(2007): 716–725; 10.1377/hlthaff.26.3.716]
T
reatments with adequate sc i ent i f i c ev idence about outcomes
can be classified as “effective” or “preference-sensitive.”1 For “effective”
treatments, the benefits far outweigh the possible harms, and the goal is to
promote their uptake, using professional and patient education, organizational
changes, and funding incentives. The best choice for “preference-sensitive” treat-
ments, in contrast, depends on how patients value benefits versus harms. Al-
though it is more difficult to judge the appropriate rate of uptake, Karen Sepucha
and colleagues propose a benchmark of “decision quality”—that is, the consis-
tency between eligible patients’ treatment uptake rates and the underlying distri-
butions of patients’ informed values.2
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We know that decision quality resulting from standard counseling is inade-
quate.3 Patients have unrealistic expectations of treatment benefits and harms,
clinicians are poor judges of patients’ values, and, as a consequence, there is over-
use of treatment options that informed patients do not value. Indeed, the use of
“preference-sensitive” surgical options (for example, hip replacement, prostatec-
tomy, hysterectomy, mastectomy, discectomy, and coronary bypass) can vary two-
to fivefold.4 Patient decision aids (informational documents designed to help
patients make decisions about treatment options), when used as adjuncts to coun-
seling, improve decision quality and reduce the overuse of surgical treatments by
25 percent.5 Decision aids differ from conventional educational materials by pre-
senting balanced personalized information about “options” in sufficient detail for
patients to arrive at informed judgments about the personal value of those op-
tions. The aim of a decision aid is to improve decision quality and to reduce related
unwarranted practice variations by (1) providing facts about the condition, op-
tions, outcomes, and probabilities; (2) clarifying patients’ evaluations of the out-
comes that matter most to them; and (3) guiding patients in the steps of delibera-
tion and communication so that a choice can be made that matches their informed
values. Decision aids are delivered as self- or practitioner-administered tools in
one-to-one or group sessions. The media for delivery vary (for example, print,
video, computer disk, and Web).
This paper summarizes progress in implementing an infrastructure to support
informed patient choice, as well as the policy initiatives required to reach the “tip-
ping point” that assures widespread adoption of decision aids as the standard of
practice for preference-sensitive care.
Infrastructure To Support Informed Patient Choice
Over the past decade or so, major progress has been made in developing the in-
frastructure needed to support a change in the standard of practice from delegated
decision making to clinical decision making based on shared decisions. The effi-
cacy of good-quality decision aids in improving the quality of clinical decision
making has been established. The infrastructure for building and maintaining li-
braries of effective decision aids is growing and improving. International consen-
sus standards for designing and testing these supports have been developed, as
have several models for implementing decision support services. National certifi-
cation standards are being developed to certify that health care organizations
meet the requirements for informed patient choice. Measures of decision quality
are under development to monitor performance and provide clinical feedback on
the quality of clinical decision making for preference-sensitive treatment choices.
And new methods for conducting the clinical evaluation of preference-sensitive
treatments are under way. The following briefly summarizes the progress that has
been made in each of these domains.
 Efficacy. The Cochrane Collaboration has systematically reviewed more than
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fifty randomized clinical trials (RCTs) of decision aids for preference-sensitive op-
tions.6 The review confirms that decision aids help patients participate in decision
making, leading to informed choices that are consistent with their values. Specifi-
cally, superior effects were shown in the form of (1) increased knowledge scores; (2)
improvements in patients’ realistic perceptions of the chances of benefits and
harms; (3) lowered scores for decisional conflict; (4) smaller numbers of patients
who are passive in decision making; (5) smaller numbers of patients who remain un-
decided after counseling; and (6) improved agreement between a patient’s values
and the option that is actually chosen. Moreover, several trials focused on decision
aids about accepting or rejecting major elective surgery have demonstrated reduc-
tions in the more invasive surgical options by 25 percent, with no adverse effects on
patient satisfaction or health outcomes.
 Cost-effectiveness. Three trials have measured the economic impact of using
patient decision aids. One U.K. trial evaluated the cost-effectiveness of aids to re-
duce hysterectomy rates in cases of heavy menstrual bleeding.7 The mean total costs
and quality-adjusted life-years (QALYs) were superior for groups exposed to
decision aids or the combination of aids with nurse coaching as follows: (1) standard
care: U.S.$2,751 per patient, 1.572 QALY; (2) aid video alone: U.S.$2,026, 1.567 QALY;
and (3) aid video plus nurse coaching (involving eliciting values for outcomes):
U.S.$1,566, 1.582 QALY. Two other cost-minimization trials of decision aids for pros-
tate enlargement treatment and menopausal hormones reported that the aid would
have been cost-neutral if less costly delivery methods were used (for example, the
Internet rather than supplying equipment for interactive videodisks).8
 Libraries of decision aids. The Cochrane Collaboration has catalogued and
evaluated the quality of a growing number of decision aids, created by a wide range
of developers (Exhibit 1).9 Examples of developers include the Foundation for In-
formed Medical Decision Making and its commercial partner, Health Dialog;
Healthwise; the Mayo Clinic; and the Ottawa Health Research Institute. U.S. organi-
zations that have compiled and are managing clearinghouses of decision aids include
the National Cancer Institute and the Centers for Disease Control and Prevention.
 International standards. The International Patient Decision Aid Standards
(IPDAS) Collaboration is a network of more than 100 researchers, practitioners, pa-
tients, and policymakers from fourteen countries.10 These collaborators have devel-
oped quality criteria in the domains of essential content (providing information,
presenting probabilities, clarifying values, and guiding deliberation and communi-
cation); development (systematic development process, balance, evidence base,
plain language, and disclosure); and evaluation (decision quality). The endorsed cri-
teria are summarized in a checklist for users, to guide payers, practitioners, patients,
developers, and researchers.
 Models for implementing decision-support services. Models include call-
center models at the health plan level (for example, Health Dialog in the United
States; BC Healthguide in Canada; and Australia Cancer Call Centers) as well as
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models that integrate decision aids into clinical practice. The use of decision aids in
call centers and public or health plan portals has expanded rapidly. For example,
high-volume decision-aid producers estimate that decision aids were accessed
about nine million times in 2006, mostly via the Internet.11
Barriers and facilitators. The use of decision aids as part of clinical care has had a
much slower rollout. A recent systematic review identified health professionals’
most commonly perceived barriers to implementing shared decision making: lack
of applicability because of patient characteristics; time constraints; lack of appli-
cability due to the clinical situation (for example, emergency situations); and per-
ceived patient preferences for a model of decision making that did not fit a shared
decision-making model.
Identified factors that facilitated shared decision making included the percep-
tion that it would lead to a positive impact on patient outcomes or the clinical pro-
cess, or both; patients’ preferences for decision-making roles fit a shared ap-
proach; health professionals were motivated to use the aids; and the perception
that shared decision making is useful or practical.12
Successful uptake of decision aids will also depend on the development of elec-
tronic infrastructures to support triggering of the aids, plus secure messaging and
patient health records to deliver them to patients. The Center for Information
Therapy is working with electronic medical record (EMR) developers and health
information producers and health care providers to define electronic “moments of
care” and provide just-in-time information before, during, and after clinical en-
counters.13
Care sites using decision aids. Despite the aforementioned barriers to uptake, sev-
eral sites of care are developing models for delivering decision aids. For example,
more than twenty Massachusetts cancer centers are using decision aids to help
patients make treatment decisions; Massachusetts General Hospital has started
an “ePrescribe” effort, where primary care physicians can prescribe decision aids
through the hospital’s EMR system; Dartmouth-Hitchcock Medical Center
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(DHMC) and White River Junction Veterans Affairs Medical Center are using
decision aids as part of a larger reengineering initiative in primary care; ten com-
munity-based primary care practices at the University of California, Los Angeles
(UCLA), are using patient decision aids; and UC San Francisco and Allegheny
General Hospital are incorporating aids into routine breast cancer care, and the
University of North Carolina is incorporating them into colorectal cancer screen-
ing.
Key role of IT systems. An important element of these practice models is the key
supportive role played by specially designed IT systems. For example, the DHMC
breast cancer program is attempting to improve clinical care quality by incorpo-
rating IT to screen patients, inform physicians, cue the decision aid, assess naïve
and informed preferences, flag emotional distress, and monitor decision quality.
Typically, the delivery of decision support involves some combination of clinical
consultation and counseling, decision aids, and coaching. The sequence, combina-
tion, and professionals involved depend on the type of decision, patient popula-
tion, and service context in which care is provided; these are being spelled out in
clinical and care pathways.14
International examples. Examples of implementing decision support also exist
outside the United States. Several urology centers in the U.K. National Health Ser-
vice (NHS) have care pathways for benign prostatic hyperplasia and early-stage
prostate cancer treatments. These involve a medical consultation with the urolo-
gist to confirm the diagnosis and to clarify the options and roles in decision mak-
ing; referral to the urology nurse specialist, who provides a decision aid about rele-
vant treatments and a personal decision form that elicits decision quality
(knowledge, values, and preferred treatment) and unresolved decisional conflict;
and a follow-up coaching visit with the nurse specialist to discuss the patient’s de-
cisional needs and next steps.15
In Canada, Ottawa Hospital is beginning to embed decision support for cancer
and obstetrical services into its care pathways as part of the informed-consent
process. In Quebec City, the implementation process of shared decision making is
being evaluated in five large family medicine sites. This program is closely associ-
ated with a residency program in family medicine. Training workshops on shared
decision making take place in each teaching site. Simple clinical tools eliciting pa-
tients’ decisional needs are disseminated through small-group learning sessions
occurring throughout the residency, and an annual three-hour training session for
clinical teachers is offered.
Developing National Certification Standards
The practice models described above can also be used as examples for develop-
ing two kinds of national standards—one for health professionals and the other
for health care organizations.
Certification for professionals would involve strategies such as the credential-
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ing of professional skills through completion of training programs. For example,
the Ottawa Health Research Institute has evaluated strategies that include auto-
tutorial and skill-building workshops in decision support and the use of decision
aids; structured decision-support protocols; and performance feedback with real
or simulated patients. Dawn Stacey and colleagues demonstrated that when this
strategy was used in a general nurse call center and in a cancer call center, practi-
tioners’ knowledge and skills in decision support improved, particularly in assess-
ing decisional needs, clarifying values, and addressing support needs.16
France Legare and colleagues have monitored the implementation of shared
decision making in the practices of 122 primary care providers. The exposure to a
training workshop, feedback, and reminder at the point of care explained a major
proportion of the behavioral intention of interest in a dose-response manner.17
In one U.K. study, primary care physicians were able to acquire the skills of
shared decision making and use risk communication aids after two sets of two
three-hour training sessions.18 The U.K. Urology Service has adapted the Ottawa
training program with its service teams; the program also includes performance
feedback on decision quality and addresses barriers to implementing decision aids
in clinical care pathways.
These training initiatives can be adapted for national roll-out. There would
need to be capacity building in training clinical teachers in shared decision mak-
ing. Integration of shared decision making would need to occur in the certification
processes of faculties of health sciences, including medicine and residency pro-
grams, and continuing medical education (CME) activities.
An example of certification for health care organizations is the convening of a
panel of experts by the National Committee for Quality Assurance (NCQA) to
work on credentialing for cancer care. The panel’s work is still in its early stages
and will focus on using available data to devise its first set of standards. The main
work to date has been developing measures to indicate the level at which an insti-
tution has implemented decision support, assessing the reliability or validity of
those measures, and piloting their inclusion in a certification process.
 Measures of “decision quality.” Measures of patients’ decision quality are
also under development.19 Decision quality refers to the extent to which patients arrive
at choices that are informed and preference-based. The Foundation for Informed
Medical Decision Making (FIMDM) is supporting research into the development of
decision-specific instruments to measure decision quality across multiple domains.
The instruments focus on assessing the extent to which patients understand the key
facts about the decision and the extent to which their choices are consistent with
their reported preferences for the good and bad outcomes of the options.
Work is under way to supplement these decision-specific measures with ge-
neric items to assess the quality of the process; both types of measures reflect the
consensus recommendations of the IPDAS collaboration. These measures will
serve as important outcome criteria for evaluating the effectiveness of providers’
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and organizations’ decision-support interventions. An NCQA expert panel is de-
veloping and piloting these kinds of measures, to demonstrate that they are valid
and reliable and can be considered for inclusion in evaluative work.
In addition, several programs have been using the measures as a screen to reveal
knowledge deficits and patients’ values before a consultation. The programs test-
ing and using both generic and decision-specific decision-quality measures in-
clude the breast cancer program and the Spine Center at the DHMC, as well as the
NHS urology services. The breast cancer centers at UCSF and at the Allegheny
General Hospital are also starting to use decision-quality measures, along with
video-based decision aids.
 Clinical evaluation of preference-sensitive treatments. This refers to the
use of decision aids and patient registries in “everyday practice” for long-term fol-
low-up studies that compare the outcomes of different treatment options when the
treatment choice has been based on patients’ preferences. The Spine Patient Out-
comes Research Trial (SPORT) of back surgery is an example that includes both an
RCT and preference-based observational arms based on informed patient choice.
This work rests on the ethical principle that trial entry for preference-sensitive
treatments should be based on informed patient choice. The rich database generated
by SPORT is providing Dartmouth investigators with the opportunity to assess out-
come probabilities under active choice versus randomization.20
Toward The ‘Tipping Point’: Emerging Opportunities For
Accelerated Change
Although progress has been made in building the infrastructure to support
shared decision making, cultural, regulatory, legal, and economic barriers must be
overcome to make informed patient choice the standard of practice for preference-
sensitive treatments. Cultural resistance resides primarily in the change required
in the doctor-patient relationship—that is, replacing the traditional reliance on
the physician’s opinion to define medical necessity with the shared decision-making
model, which defines new roles for both patient and physician. The good news is
that the research and development agenda described above has established that
patients and physicians who participate in shared decision making make better
decisions and are comfortable in their new roles. The bad news is that shared
decision making remains the exception, not the rule.
To take the next steps to the “tipping point,” the health policy community
needs to develop new standards for defining the medical necessity of preference-
sensitive treatment options. Health plans and employers need to develop new pay-
ment strategies that encourage both patients and providers to participate in
shared decision making. The legal profession needs to recognize the limitations of
traditional informed consent in assuring shared decision making and adopt a new
standard based on the requirements for achieving informed patients through
shared decision making. Each of these changes is amplified below.
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 New standards for medical necessity. The standard for review of medical
necessity now commonly exercised by the Centers for Medicare and Medicaid Ser-
vices (CMS) and private health plans is based on the physician as the determinant of
medical necessity. We envision a different standard based on the assertion that the
informed patient is the final arbiter of the necessity of preference-sensitive treat-
ment. Under our recommendation, the medical profession would continue to deter-
mine which options are reasonable, and health plans would determine which op-
tions are covered. The process of informed patient choice should be well defined,
transparent, and subject to review (along the lines discussed above). Decision aids
should be assessed by external standards to ensure that they provide evidence-
based, up-to-date, balanced information on all relevant treatment options and that
they promote the clarification of values. Quality should be evaluated and reported
using appropriate patient decision-quality measures. This process would also be
certified or accredited.21
 New payment strategies. The economic incentives embedded in traditional
Medicare and most other payers reward providers for utilization, not for informed
patient choice. Pay-for-performance (P4P) models that reward providers who im-
plement shared decision making need to be designed and tested through demonstra-
tions.22 The effectiveness of health savings accounts (HSAs) and other “consumer-
choice” strategies for involving patients in choice of discretionary treatments should
increase patients’ demand for shared decision making, but these models need to be
tested. We believe that the existence of certification processes and decision-quality
measures would provide the basis for qualifying providers for reimbursement and
for monitoring the outcomes of the decision process.
 Informed patient choice as the legal standard. We concur with several le-
gal commentators who have suggested that the states should rethink current in-
formed-consent requirements and adopt shared medical decision making as a pre-
requisite to valid, informed patient choice. The states are largely divided between
two categories of informed-consent standards: physician-based and patient-based.
In physician-based states, physicians must provide patients with the same informa-
tion that a reasonable physician would under similar circumstances.23 In patient-
based states, physicians must provide patients with all of the information that an
objective, reasonable patient would want under similar circumstances.24
Both standards prove insufficient, but for different reasons. The physician-
based standard does not acknowledge that often no true objective standard for
physicians exists.25 In fact, reasonable physicians exhibit wide variations in prac-
tice patterns even within the same region. Likewise, the objective patient stan-
dard used in nearly all patient-based states does not go far enough to protect a pa-
tient’s right to make medical decisions.26 It fails to acknowledge that patients’
values and preferences vary widely. In many cases, a patient’s lifestyle, values, and
preferences should dictate what course of treatment to follow. Under the objective
patient standard, to the extent that the person’s preferences do not correspond
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with those of a “reasonable” patient, however defined, that person may be denied
information that he or she would deem relevant to making the treatment deci-
sion.27 Shared medical decision making offers a promising alternative to our cur-
rent informed-consent system. It allows both physicians and patients to honor the
values and preferences of the patient, while also permitting the physician to pro-
vide medical expertise to promote the patient’s health. In fact, evidence suggests
that shared medical decision making strengthens the therapeutic alliance be-
tween the physician and patient and improves patient satisfaction.
Critics of the shared decision-making approach have questioned the feasibility
of proving that a true shared process had occurred, but the certification processes
of care and decision quality measures discussed previously should provide trans-
parent ways of measuring whether the standard of informed choice has been met.
T
o reach the t i pp ing po int, we need to make the use of high-quality
decision aids unavoidable and a part of the informed-consent process. The
best way to accomplish the ease of prescription is to embed high-quality
decision aids within EMR systems. At the national policy level, we need to design
and introduce model legislation about informed patient choice, as well as to con-
vene payer groups under the leadership of the CMS to redefine the patient’s role in
determining medical necessity and claims review. National policies focused on in-
formed consent, a redefinition of medical necessity, and new payment strategies
should accelerate adoption of informed patient choice as the standard for practice,
with resulting benefits to patients, physicians, and the health care community.
Annette O’Connor, Hilary Llewellyn-Thomas, and Karen Sepucha receive research funds from the Foundation for
Informed Medical Decision Making (FIMDM). The FIMDM, a nonprofit, has a licensing agreement with Health
Dialog, a commercial company that promotes the use of patient decision aids. John Wennberg is a consultant for the
FIMDM and has a financial interest in Health Dialog.
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